Skip to content
AnalystLens
Back to EXELIncome Statement

Exelixis Revenue 2009-2027 | EXEL

Annual FY2009–FY2026 · quarterly through Q3 FY2027

Latest annual · FY2026

$2.32B

+7.0%YoY vs FY2025Source: 10-KFY2026

From $151.8M in FY2009 to $2.32B in FY2026: 15.3× in 17 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY27$611M+10.0%$629M+10.6%$659M+10.2%Not reported
FY26$555M+30.6%$568M−10.8%$598M+10.8%$599M+5.6%
FY25$425M$637M$540M$567M
FY23$409M+14.8%$470M+12.0%$472M+14.6%$643M+2.5%
FY22$356M+31.7%$419M+8.9%$412M+25.4%$627M
Share22%25%25%28%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+19.1%

FY2020
$967.8M
FY2026
$2.32B

5 years selected · on the chart

Revenue History

Year-over-year comparison from 10-K annual reports

  1. $2.32B
YoY changeLargest recent move+88.7%in FY18Latest +7.0%

1 older move runs past ±150% (largest +1117.3%); point at, tap or drag across the bars to read one.

Revenue, period by period

PeriodValueChangeSource
FY2026$2.32B+7.0%10-K
FY2025$2.17B+18.5%10-K
FY2023$1.83B+13.6%10-K
FY2022$1.61B+12.3%10-K
FY2021$1.43B+48.3%10-K
FY2020$967.8M+13.3%10-K
FY2018$853.8M+88.7%10-K
FY2017$452.5M+1117.3%10-K
FY2016$37.2M0.0%flat10-K
FY2015$37.2M+48.0%10-K
FY2014$25.1M−19.9%10-K
FY2013$31.3M−34.0%10-K
FY2012$47.5M−83.6%10-K
FY2011$289.6M+56.5%10-K
FY2010$185.0M+21.9%10-K
FY2009$151.8M—10-K

What is revenue?

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

What is Exelixis's current revenue?

Exelixis (EXEL) annual revenue for 2026 was $2.32B, a 6.98% increase from 2025. Exelixis revenue for the quarter ending October 2, 2026 was $658.7M.

What was Exelixis's revenue in 2025?

Exelixis annual revenue for 2025 was $2.17B, a 18.49% increase from 2023.

What was Exelixis's revenue in 2023?

Exelixis annual revenue for 2023 was $1.83B, a 13.60% increase from 2022.

What is Exelixis's 5-year revenue CAGR?

Exelixis revenue grew at a compound annual growth rate (CAGR) of 10.09% from FY2021 to FY2026, going from $1.43B to $2.32B over 5 years.

Company
Exelixis
Ticker
EXEL
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)